Novel therapeutic agents: Lumiracoxib, a novel COX-2 selective inhibitor, is effective in the treatment of episodic tension-type headache
2004
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI